Azactam and Rashes - a phase IV clinical study of FDA data

Summary:

Rashes is reported as a side effect among people who take Azactam (aztreonam), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Vancomycin, and have Infection.

The phase IV clinical study analyzes which people have Rashes when taking Azactam. It is created by eHealthMe based on reports of 1,039 people who have side effects when taking Azactam from the FDA, and is updated regularly.

What is Azactam?

Azactam has active ingredients of aztreonam. eHealthMe is studying from 1,044 Azactam users. Check the latest studies of Azactam.

What is Rashes?

Rashes (redness) is found to be associated with 3,715 drugs and 6,214 conditions by eHealthMe. Check the latest studies of Rashes.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

1,039 people reported to have side effects when taking Azactam.
Among them, 89 people (8.57%) have Rashes.

Among these 89 people:

How long have people been on Azactam when they have Rashes? *

What is the gender of people who have Rashes when taking Azactam? *

female: 62.2 %
male: 37.8 %

What is the age of people who have Rashes when taking Azactam? *

What are other drugs people take besides Azactam? *

Vancomycin: 28 people, 31.46%
Crestor: 18 people, 20.22%
Haldol: 18 people, 20.22%
Midazolam: 14 people, 15.73%
Tranxene: 14 people, 15.73%
Pantoprazole: 11 people, 12.36%
Cyclophosphamide: 10 people, 11.24%
Piperacillin And Tazobactam: 9 people, 10.11%
Ciprofloxacin: 8 people, 8.99%
Vincristine Sulfate: 8 people, 8.99%

What are other side effects people have besides Rashes? *

Eosinophilia (eosinophil count in the peripheral blood exceeds): 32 people, 35.96%
Itching: 19 people, 21.35%
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 19 people, 21.35%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 15 people, 16.85%
Circulatory Collapse: 15 people, 16.85%
Acute Kidney Failure: 9 people, 10.11%
Oedema Peripheral (superficial swelling): 8 people, 8.99%
Skin Exfoliation (removal of the oldest dead skin cells): 6 people, 6.74%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 6 people, 6.74%
Immunoglobulins Decreased: 5 people, 5.62%

What are the existing conditions these people have? *

Device Related Infection: 19 people, 21.35%
Infection: 19 people, 21.35%
Gastritis (inflammation of stomach): 17 people, 19.10%
Dyslipidaemia (abnormal amount of lipids): 17 people, 19.10%
Lymphoma (cancer that begins in immune system cells): 10 people, 11.24%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 10 people, 11.24%
Pain: 8 people, 8.99%
Depression: 6 people, 6.74%
Iron Deficiency: 5 people, 5.62%
Osteitis (a general term for inflammation of bone): 5 people, 5.62%

* Approximation only. Some reports may have incomplete information.

Do you take Azactam and have Rashes?

- Check whether Rashes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azactam:

Azactam (1,044 reports)

Rashes treatments and more:

Rashes (702,909 reports)

Browse all side effects of Azactam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rashes:

Rashes (3,715 drugs)

Browse all the conditions that are associated with Rashes:

Rashes (6,214 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aztreonam (the active ingredients of Azactam) and Azactam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.